Automated, Accurate and Accessible
Cervical Cancer Screening

Founded by Columbia University biomedical engineers, Luso Labs LLC addresses critical problems
encountered during visual inspection with acetic acid testing through the cerVIA system.

The Cervical Cancer Pandemic

While pap smears and HPV vaccines have curbed the prevalence of cervical cancer in countries like the United States, the disease kills hundreds of thousands of women in low and middle-income countries every year.

The cerVIA Screening System

Coupling a custom camera system with a lesion detection algorithm in a speculum-fitted device, the cerVIA screening system detects precancerous lesions on the ectocervix in a manner that integrates easily into existing clinical practices.

Let's start talking

With a goal to reach patients within 3 years, our team welcomes feedback, collaborations and funding opportunities.